Semaglutide and pregnancy

Int J Gynaecol Obstet. 2023 Nov;163(2):699-700. doi: 10.1002/ijgo.15092. Epub 2023 Sep 8.

Authors

Kenneth Skov^{1

2}, Ida Nikoline Mandic³, Kathinka Marie Nyborg⁴

Affiliations

¹ Clinical Pharmacology Unit, Zealand University Hospital Roskilde, Roskilde, Denmark.
² Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.
³ Pediatric Unit, Slagelse Hospital, Slagelse, Denmark.
⁴ Department of Obstetrics and Gynecology, Fetal Medicine Unit, Slagelse Hospital, Slagelse, Denmark.

PMID: 37688299
DOI: 10.1002/ijgo.15092

No abstract available

Keywords: PCOS; case report; malformations; overweight; pregnancy; risk pregnancy; semaglutide; untoward fetal outcome.

MeSH terms

Diabetes Mellitus, Type 2*
Female
Glucagon-Like Peptides* / adverse effects
Humans
Hypoglycemic Agents / adverse effects
Overweight
Pregnancy
Pregnancy Outcome*

Substances

Glucagon-Like Peptides
Hypoglycemic Agents
semaglutide